34 Results for "

U266

" in MedChemExpress (MCE) Product Catalog:
Products (34)

34 Results for "U266" in MCE Product Catalog:

28
28 Publications Verification
Cat. No.: HY-15473A
CAS No.: 1782573-78-7
Purity:  99.73%
Synonyms: ML120B dihydrochloride
Target:  

IKK

Research Areas:  

Inflammation/Immunology Cancer

MLN120B dihydrochloride (ML120B dihydrochloride) is a potent, ATP competitive, and orally active inhibitor of IKKβ with an IC50 of 60 nM. MLN120B inhibits multiple myeloma cell growth in vitro and in vivo and also can be used for the research of rheumatoid arthritis .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-B1046
CAS No.: 2030-63-9
Clofazimine is an orally-active anti-mycobacterial agent with a wide range of anti-mycobacterial activity including leprosy and tuberculosis. Clofazimine exerts anti-inflammatory activities and anti-tumor activities by interfering DNA replication and inhibiting IL2 (IC50 = 1.10 ± 0.26 μM, Jurkat T) production. Clofazimine can be used in mycobacterial and cancer research .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-101291
CAS No.: 1323403-33-3
Purity:  99.54%
Synonyms: CC-220
Iberdomide (CC-220) is an orally active and potent cereblon (CRBN) E3 ligase modulator (CELMoD) with an IC50 of ~150 nM for cereblon-binding affinity. Iberdomide, a derivative of Thalidomide (HY-14658), has antitumor and immunostimulatory activities .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-19322B
CAS No.: 1820565-69-2
Synonyms: LGH447 dihydrochloride
Target:  

Pim Apoptosis

Research Areas:  

Cancer

PIM447 dihydrochloride (LGH447 dihydrochloride) is a potent, orally available, and selective pan-PIM kinase inhibitor, with Ki values of 6, 18, and 9 pM for PIM1, PIM2, and PIM3, respectively. PIM447 dihydrochloride displays dual antimyeloma and bone-protective effects. PIM447 dihydrochloride induces apoptosis .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-13560
CAS No.: 297730-17-7
Purity:  99.89%
Synonyms: VX-944
AVN-944 (VX-944) is an orally active, potent, selective, noncompetitive and specific inhibitor of IMPDH (inosine monophosphate dehydrogenase). AVN-944 is an essential rate-limiting enzyme in de novo guanine nucleotide synthesis. AVN-944 is also an inhibitor of arenavirus RNA synthesis, and blocks arenavirus infection. AVN-944 has broad anti-cancer activities, and can be used for multiple myeloma (MM) and acute myeloid leukemia (AML) research .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-100515
CAS No.: 1132653-79-2
Purity:  99.42%
Target:  

Hedgehog

Research Areas:  

Inflammation/Immunology

Robotnikinin is a small molecule capable of binding to and inhibiting the activity of Sonic Hedgehog (Shh) signaling up stream of Smo .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B0812
CAS No.: 5965-83-3
Synonyms: SSA dihydrate
5-Sulfosalicylic acid dihydrate is a sulfonated salicylic acid derivative. 5-Sulfosalicylic acid dihydrate is effective against the breast cancer cell line, MCF-7, with less toxicity . 5-Sulfosalicylic acid dihydrate has antioxidant activities .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N0840
CAS No.: 41451-75-6
Synonyms: (-)-Bruceantin; NCI165563; NSC165563
Bruceantin ((-)-Bruceantin) is a quassinoid found in B. javanica. Bruceantin activates caspase signaling pathway, causes the mitochondrial dysfunction, inhibits cell proliferation, induces cell differentiation and apoptosis. Bruceantin exhibits anti-leukemia and antiprotozoal activities .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-111451
CAS No.: 1613200-51-3
Purity:  99.75%
Synonyms: M1774; ATR inhibitor 1
Target:  

ATM/ATR

Research Areas:  

Cancer

Tuvusertib (M1774; ATR inhibitor 1) is a selective and orally active ATR inhibitor extracted from patent WO2015187451A1, compound I-l, with a Ki value below 1 μΜ .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N2116
CAS No.: 111047-30-4
Ginkgolic acid C17:1 is a fatty acid synthase (FAS) inhibitor with an IC50 of 10.5 µM. Ginkgolic acid C17:1 shows anti-tumor activity by inhibiting the phosphorylation of STAT3 and inducing apoptosis. Ginkgolic acid C17:1 can block the interaction between S-RBD and ACE2, and has anti-SARS-CoV-2-S pseudovirus activity. Ginkgolic acid C17:1 inhibits the biofilm formation of enterohemorrhagic Escherichia coli and Staphylococcus aureus .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-125927
CAS No.: 3868-33-5
Purity:  99.94%
Synonyms: 8-NH2-Ado
8-Aminoadenosine (8-NH2-Ado), a RNA-directed nucleoside analogue, reduces cellular ATP levels and inhibits mRNA synthesis. 8-Aminoadenosine blocks Akt/mTOR signaling and induces autophagy and apoptosis in a p53-independent manner. 8-Aminoadenosine has antitumor activity .
loading...
    loading...
Cat. No.: HY-122657
CAS No.: 1881276-00-1
Purity:  98.92%
Target:  

RUNX

Research Areas:  

Cancer

AI-10-104 is an inhibitor for runt-related transcription factor (RUNX), which enhances the cytotoxicity in myeloma cells .
loading...
    loading...
Cat. No.: HY-N8309
CAS No.: 6920-38-3
Luteolin-4'-O-glucoside is an IL-5 inhibitor with an IC50 of 3.7 μM. Luteolin-4'-O-glucoside resists hyperuricemia and acute gouty arthritis activity. Luteolin-4'-O-glucoside shows anticancer activity .
loading...
    loading...
Cat. No.: HY-151168
CAS No.: 32744-80-2
Purity:  99.70%
Research Areas:  

Inflammation/Immunology Cancer

3-Chlorogentisyl alcohol is a potent E. coli β-glucuronidase inhibitor with an IC50 value of 0.74 μM, an Ki value of 0.58 μM. 3-Chlorogentisyl alcohol shows antiproliferative activity. 3-Chlorogentisyl alcohol has the potential for the research of anti-cancer and anti-inflammatory therapies .
loading...
    loading...
Cat. No.: HY-P991183

Target:  

CD28 CD38 CD3

Research Areas:  

Cancer

SAR-442257 is a trispecific T-cell engager and monoclonal antibody that binds to CD38, CD3 and CD28. SAR-442257 can target and bind to CD3 and CD28 on T cells, as well as CD38 expressed on tumor cells. SAR-442257 mediates T-cell activation, enhances T-cell activity, induces T-cell degranulation, and drives cytotoxicity against multiple myeloma cells. SAR-442257 functions via CD38 expression, and its in vitro activity correlates with CD38 expression on the surface of multiple myeloma cells. SAR-442257 can be used in studies related to multiple myeloma and relapsed/refractory multiple myeloma .
loading...
    loading...
Cat. No.: HY-152133
CAS No.: 2785404-76-2
Target:  

PROTACs HDAC Apoptosis

Research Areas:  

Cancer

PROTAC HDAC6 degrader (Compound A6) is a potent and selective PROTAC HDAC6 degrader with a DC50 of 3.5 nM. PROTAC HDAC6 degrader shows promising antiproliferative activity via inducing apoptosis in myeloid leukemia cell lines .
loading...
    loading...
Cat. No.: HY-101291R
CAS No.: 1323403-33-3
Synonyms: CC-220 (Standard)
Iberdomide (Standard) is the analytical standard of Iberdomide. This product is intended for research and analytical applications. Iberdomide (CC-220) is an orally active and potent cereblon (CRBN) E3 ligase modulator (CELMoD) with an IC50 of ~150 nM for cereblon-binding affinity. Iberdomide, a derivative of Thalidomide (HY-14658), has antitumor and immunostimulatory activities .
loading...
    loading...
Cat. No.: HY-177768
CAS No.: 3055552-13-8
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

HDAC-IN-96 (Compound 3f) is a selective HDAC1/2 inhibitor with IC50 values of 457.1 and 433.7 nM. HDAC-IN-96 has strong inhibitory activity against multiple hematological tumor cells (RS4;11, K562, RPMI-8226, U266), with IC50 values ranging from 2.11 to 5.35 μM. HDAC-IN-96 can induce cancer cells apoptosis and S phase arrest. HDAC-IN-96 can be used for the research of cancer, such as acute lymphoblastic leukemia .
loading...
    loading...
Cat. No.: HY-112447
CAS No.: 1041438-68-9
Target:  

STAT

Research Areas:  

Cancer

STAT3-IN-5 is a potent STAT3 inhibitor. STAT3-IN-5 inhibits STAT3-Y705 phosphorylation with an EC50 value of 170 nM. STAT3-IN-5 inhibits cytokine induced JAK activation. STAT3-IN-5 induces apoptosis. STAT3-IN-5 can be used in research of cancer .
loading...
    loading...
Cat. No.: HY-155671
CAS No.: 2998942-88-2
Target:  

HDAC

Research Areas:  

Cancer

HDAC6-IN-18 (Compound 4) is a first irreversible HDAC6 isoform selective inhibitor with potent anti-multiple myeloma activity. HDAC6-IN-18 has HDAC6 inhibitory activity in RPMI8266, U266 and MM.1S cells with IC50 values of 0.17, 0.7 and 0.42 μM, respectively .
loading...
    loading...